LUMIPHORE

Lumiphore is a radiopharmaceutical company leveraging novel macrocyclic BiFunctional Chelate (mBFC) technology into diagnostic and therapeutic constructs to improve human health. With deep domain knowledge regarding metals in medicine, Lumiphore is applying decades of chelation expertise to both existing and novel cancer targeting agents to create best-in-class medicines. These novel constructs allow for rapid, room temperature chelation of a wide range of promising radioisotopes, with high in-vivo stability covering imaging and therapeutics with a single compound matched with multiple radionuclides... Lumiphore is a revenue stage biotechnology company, spun out of Dr. Kenneth Raymond's laboratory, Department of Chemistry, University of California, Berkeley in 2001... Lumiphore has leveraged proprietary chelation technology into multiple projects internally and with partners to bring next-generation radiopharmaceuticals into the clinic. We are actively seeking partners with novel..

Primary location: Berkeley United States